Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.19.1
Shareholders' Deficit (Tables)
 3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Schedule of nonvested activity
   

Number of

Non-vested Shares

     Weighted Average Grant Date Fair Value  
Non-vested, December 31, 2018     5,998,672     $ 0.61  
Granted     200,000       -  
Forfeited     -       -  
Non-vested, March 31, 2019     6,198,672     $ 0.61  
Schedule of stock option activities
    Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic
Value		  
Balance Outstanding, December 31, 2018     11,445,698     $ 0.30                  
Granted     -       -                  
Exercised     -       -                  
Forfeited     -       -                  
Balance Outstanding, March 31, 2019     11,445,698     $ 0.30       6.42     $ 468,000  
Exercisable, March 31, 2019     9,811,195     $ 0.30       6.08     $ 468,000  
Schedule of warrant activities
    Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic
Value		  
Balance Outstanding December 31, 2018     -     $ -       -     $           -  
Granted     1,000,000       0.18                  
Cancelled     -       -                  
Balance Outstanding  March 31, 2019     1,000,000     $ 0.18       4.96     $ 0  
Exercisable, March 31, 2019     200,000     $ 0.18       4.96     $ 0